Literature DB >> 8862748

Aluminum chelation by 3-hydroxypyridin-4-ones in the rat demonstrated by microdialysis.

R A Yokel1.   

Abstract

The ability and site of the metal-chelating 3-hydroxypyridin-4-ones (HPs) to mobilize aluminum (Al) was assessed in Al-loaded rats using microdialysis. Four HPs with greatly varying lipophilicity were studied. One week after Al loading, microdialysis probes were implanted in the liver, a jugular vein, and the frontal cortex. An HP was given iv followed by continuous microdialysis for 5 h. Al concentrations in dialysates from the liver increased rapidly and were consistently greater than from blood, suggesting that liver was a primary site of Al chelation. Brain dialysate Al concentrations remained low, suggesting little Al chelation in the brain and little distribution of the Al HP complex into the brain. Al concentrations were determined in the main organs/tissues of a separate group of Al-loaded rats, and the percentage of the total Al body burden in each organ/tissue was calculated. The skeletal system and liver had 57 and 28% of the Al body burden, consistent with the liver as a primary site of Al chelation. The HPs chelate extravascular Al and have been shown by others to be orally active. They warrant further investigation as Al chelators.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862748     DOI: 10.1007/BF02784555

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  22 in total

1.  The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat.

Authors:  A M Fredenburg; R K Sethi; D D Allen; R A Yokel
Journal:  Toxicology       Date:  1996-04-30       Impact factor: 4.221

2.  Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.

Authors:  S Zevin; G Link; R W Grady; R C Hider; H H Peter; C Hershko
Journal:  Blood       Date:  1992-01-01       Impact factor: 22.113

3.  Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.

Authors:  R A Yokel; A M Fredenburg; K A Meurer; T L Skinner
Journal:  Drug Metab Dispos       Date:  1995-10       Impact factor: 3.922

4.  Evaluation of potential aluminum chelators in vitro by aluminum solubilization ability, aluminum mobilization from transferrin and the octanol/aqueous distribution of the chelators and their complexes with aluminum.

Authors:  R A Yokel; A K Datta; E G Jackson
Journal:  J Pharmacol Exp Ther       Date:  1991-04       Impact factor: 4.030

5.  Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant.

Authors:  J B Porter; M Gyparaki; L C Burke; E R Huehns; P Sarpong; V Saez; R C Hider
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

6.  Aluminum distribution into brain and liver of rats and rabbits following intravenous aluminum lactate or citrate: a microdialysis study.

Authors:  R A Yokel; V Lidums; P J McNamara; U Ungerstedt
Journal:  Toxicol Appl Pharmacol       Date:  1991-01       Impact factor: 4.219

7.  Binding of aluminium to plasma proteins: comparative effect of desferrioxamine and deferiprone (L1).

Authors:  J L Fernández-Martín; P Menéndez-Fraga; M A Canteros; J B Díaz-López; J B Cannata-Andía
Journal:  Clin Chim Acta       Date:  1994-10-31       Impact factor: 3.786

8.  Comparative aluminium mobilizing actions of several chelators in aluminium-loaded uraemic rats.

Authors:  M Gómez; J L Domingo; D del Castillo; J M Llobet; J Corbella
Journal:  Hum Exp Toxicol       Date:  1994-02       Impact factor: 2.903

9.  Evidence for energy-dependent transport of aluminum out of brain extracellular fluid.

Authors:  D D Allen; C Orvig; R A Yokel
Journal:  Toxicology       Date:  1995-04-12       Impact factor: 4.221

Review 10.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

View more
  1 in total

Review 1.  Pharmacokinetic and metabolism studies using microdialysis sampling.

Authors:  D K Hansen; M I Davies; S M Lunte; C E Lunte
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.